Pharos Pharmaceuticals Inc.
Records under this name other than patents Pharos Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Pharos Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,045,523 | Compounds Formerly held Lapsed on the fee record Ended Jun 2, 2023 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2023 | USPTO record |
| US 6,770,635 | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions Lapsed on the fee record Ended Aug 3, 2012 · USPTO record | Lapsed on the fee record | Ended Aug 3, 2012 | USPTO record |
| US 5,631,245 | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions Term ended Term ended no later than May 20, 2017 · Low confidence | Term ended | Term ended no later than May 20, 2017 | Low confidence |